{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:14:15Z","timestamp":1775790855150,"version":"3.50.1"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.10775","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T15:31:15Z","timestamp":1621611075000},"page":"e2110775","source":"Crossref","is-referenced-by-count":19,"title":["Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic"],"prefix":"10.1001","volume":"4","author":[{"given":"Jonathan H.","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy Practice, University of California Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of California, Irvine Donald Bren School of Information and Computer Sciences, Irvine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Nan","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of California, Irvine Donald Bren School of Information and Computer Sciences, Irvine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira R.","family":"Abeles","sequence":"additional","affiliation":[{"name":"Antimicrobial Stewardship, Infection Prevention and Clinical Epidemiology, Department of Medicine, University of California, San Diego School of Medicine, La Jolla"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy Practice, University of California Irvine School of Pharmacy & Pharmaceutical Sciences, Irvine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay R.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Infectious Disease Section, VA San Diego Clinical Microbiology Laboratory, VA San Diego, La Jolla, California"},{"name":"Department of Medicine, UC San Diego School of Medicine, La Jolla, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"issue":"3","key":"zld210086r3","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","article-title":"Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report.","volume":"158","author":"Moores","year":"2020","journal-title":"Chest"},{"issue":"1","key":"zld210086r5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"21","key":"zld210086r6","first-page":"2030","article-title":"Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.","volume":"383","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"key":"zld210086r1","unstructured":"COVID-19 Map. Johns Hopkins Coronavirus Resource Center. Accessed March 12, 2021. https:\/\/coronavirus.jhu.edu\/map.html"},{"key":"zld210086r2","unstructured":"COVID-19 Treatment Guidelines\u2014Therapeutic Management. National Institutes of Health. Accessed March 8, 2021. https:\/\/www.covid19treatmentguidelines.nih.gov\/therapeutic-management\/"},{"key":"zld210086r4","unstructured":"US Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment. Press release. Published May 1, 2020. Accessed April 16, 2021. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2780277\/watanabe_2021_ld_210086_1620949816.81853.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T15:31:23Z","timestamp":1621611083000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2780277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.10775","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]}}}